|
|
||||||||
The Journal of Immunology, Vol 153, Issue 12 5433-5442, Copyright © 1994 by American Association of Immunologists
ARTICLES |
A Kuruvilla, C Pielop and WT Shearer
Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030.
Platelet-activating factor (PAF) is a versatile lipid mediator of inflammation in a variety of biologic systems. We have previously reported that one of the earliest events in the signal transduction pathway of PAF in a human B lymphoblastoid cell line was the induction of tyrosine kinase activity concomitant with the activation of phospholipase C (PLC). We now demonstrate the occurrence of multiple tyrosine phosphorylation-dependent events which follow the interaction of PAF with its receptor on B cells. Anti-phosphotyrosine immunoprecipitates from lysates of PAF-stimulated cells, when fractionated by SDS-PAGE and analyzed by Western blotting with anti-PLC- gamma 1, showed that maximal tyrosine phosphorylation of this enzyme occurred within 2 min of stimulation. This phenomenon was verified by immunoprecipitating with anti-PLC-gamma 1 and subsequently probing with anti-phosphotyrosine. Immunoprecipitation of the tyrosine kinases, Fyn and Lyn, from PAF-stimulated cells, and use of these immunoprecipitates in kinase assays established that the activation of both kinases also occurred within the first 2 min of stimulation with phosphorylation occurring on their tyrosine residues. Additionally, we also provide evidence for the tyrosine phosphorylation of the p85 subunit of phosphatidylinositol 3-kinase (PtdIns 3-kinase) and activation of this kinase by PAF in a dose-dependent manner, maximal activation occurring within 10 min post-stimulation. We have thus demonstrated that the activation of tyrosine kinases is an important proximate step in PAF- mediated signal transduction in B cells, leading to tyrosine phosphorylation and activation of PLC-gamma 1, Fyn and Lyn kinases, and PtdIns 3-kinase.
This article has been cited by other articles:
![]() |
Y. Li, V. Chandrakanthan, M. L Day, and C. O'Neill Direct Evidence for the Action of Phosphatidylinositol (3,4,5)-Trisphosphate-Mediated Signal Transduction in the 2-Cell Mouse Embryo Biol Reprod, November 1, 2007; 77(5): 813 - 821. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. O. Melnikova, A. A. Mourad-Zeidan, D. C. Lev, and M. Bar-Eli Platelet-activating Factor Mediates MMP-2 Expression and Activation via Phosphorylation of cAMP-response Element-binding Protein and Contributes to Melanoma Metastasis J. Biol. Chem., February 3, 2006; 281(5): 2911 - 2922. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hudry-Clergeon, D. Stengel, E. Ninio, and I. Vilgrain Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase FASEB J, April 1, 2005; 19(6): 512 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Deo, N. G. Bazan, and J. D. Hunt Activation of Platelet-activating Factor Receptor-coupled G{alpha}q Leads to Stimulation of Src and Focal Adhesion Kinase via Two Separate Pathways in Human Umbilical Vein Endothelial Cells J. Biol. Chem., January 30, 2004; 279(5): 3497 - 3508. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lukashova, Z. Chen, R. J. Duhe, M. Rola-Pleszczynski, and J. Stankova Janus Kinase 2 Activation by the Platelet-Activating Factor Receptor (PAFR): Roles of Tyk2 and PAFR C Terminus J. Immunol., October 1, 2003; 171(7): 3794 - 3800. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhuang, Y. Bastien, and B. D. Mazer Activation Via Multiple Signaling Pathways Induces Down-Regulation of Platelet-Activating Factor Receptors on Human B Lymphocytes J. Immunol., September 1, 2000; 165(5): 2423 - 2431. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Moratz, V. H. Kang, K. M. Druey, C.-S. Shi, A. Scheschonka, P. M. Murphy, T. Kozasa, and J. H. Kehrl Regulator of G Protein Signaling 1 (RGS1) Markedly Impairs Gi{alpha} Signaling Responses of B Lymphocytes J. Immunol., February 15, 2000; 164(4): 1829 - 1838. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yu, J. Cassara, and P. F. Weller Phosphatidylinositide 3-kinase localizes to cytoplasmic lipid bodies in human polymorphonuclear leukocytes and other myeloid-derived cells Blood, February 1, 2000; 95(3): 1078 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Bastien, B. J. Toledano, N. Mehio, L. Cameron, B. Lamoukhaid, P. Renzi, Q. Hamid, and B. D. Mazer Detection of Functional Platelet-Activating Factor Receptors on Human Tonsillar B Lymphocytes J. Immunol., May 1, 1999; 162(9): 5498 - 5505. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ali, I. Fisher, B. Haribabu, R. M. Richardson, and R. Snyderman Role of Phospholipase Cbeta 3 Phosphorylation in the Desensitization of Cellular Responses to Platelet-activating Factor J. Biol. Chem., May 2, 1997; 272(18): 11706 - 11709. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Ferby, I. Waga, M. Hoshino, K. Kume, and T. Shimizu Wortmannin Inhibits Mitogen-activated Protein Kinase Activation by Platelet-activating Factor through a Mechanism Independent of p85/p110-type Phosphatidylinositol 3-Kinase J. Biol. Chem., May 17, 1996; 271(20): 11684 - 11688. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ali, E. D. Tomhave, R. M. Richardson, B. Haribabu, and R. Snyderman Thrombin Primes Responsiveness of Selective Chemoattractant Receptors at a Site Distal to G Protein Activation J. Biol. Chem., February 9, 1996; 271(6): 3200 - 3206. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lukashova, C. Asselin, J. J. Krolewski, M. Rola-Pleszczynski, and J. Stankova G-protein-independent Activation of Tyk2 by the Platelet-activating Factor Receptor J. Biol. Chem., June 22, 2001; 276(26): 24113 - 24121. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |